NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,066 | +0.9% | 89 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,981 | +306.7% | 89 | +270.8% | 0.00% | +200.0% |
| Q1 2023 | $2,208 | +1.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,177 | -99.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,824,000 | -10.1% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,029,000 | -9.8% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,250,000 | +7.2% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,099,000 | +6.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,963,000 | -4.3% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,052,000 | -9.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,266,000 | +8.6% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,087,000 | -0.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,096,000 | +104700.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |